Clinical Trial Update: Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intensity-modulated radiation therapy (IMRT) with 3-D conformal radiation therapy to reduce hearing loss after surgery for parotid gla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Ototoxicity
• Parotid Gland Neoplasms
• Radiation Toxicity

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Head and Neck Cancer, Ototoxicity | Phase 3 | Status: UNKNOWN